POINT Biopharma Global
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has POINT Biopharma Global's balance sheet done over the years? Its assets were worth $578,322,736 last year, which is more than in the previous period. 16% of POINT Biopharma Global’s total assets is currently financed by debt. Its liabilities reached the amount of $91,368,943, which means an increase by 1036% compared compared to last year.
Debt to Assets
| 2019 | 1176 | 10.4K | 884.35% |
|---|---|---|---|
| 2020 | 22194495 | 8.71M | 39.26% |
| 2021 | 263258642 | 8.04M | 3.06% |
| 2022 | 578322736 | 91.36M | 15.8% |
PNT Balance Sheet (2019 – 2022)
| 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|
Assets | ||||
Current assets: | ||||
Cash and cash equivalents | 286.42M | 238.81M | 10.54M | 0 |
Short term investments | 238.78M | 0 | 135.70B | 0 |
Net receivables | 60.22K | 72.66K | 58.98K | 0 |
Inventory | 5.33M | 4.85M | 1.76M | 0 |
Other current assets | 215.19K | 105.45K | 27.63K | 1.17K |
Total current assets | 530.82M | 243.84M | 12.39M | 1.17K |
Non-current assets: | ||||
Property, Plant and Equipment | 31.38M | 19.41M | 9.79M | 0 |
Goodwill | 0 | 0 | 0 | 0 |
Intangible assets | 0 | 0 | 0 | 0 |
Long term investments | 16.11M | 0 | 0 | 0 |
Other non-current assets | -47.50M | -19.41M | -9.79M | 0 |
Total non-current assets | 47.50M | 19.41M | 9.79M | 0 |
Total assets | 578.32M | 263.25M | 22.19M | 1.17K |
Liabilities | ||||
| Current liabilities: | ||||
Accounts payable | ||||
Deferred revenue | 23.24M | 0 | 0 | 0 |
Short term debt | 0 | 0 | 0 | 0 |
Total current liabilities | 79.73M | 7.97M | 5.16M | 10.4K |
| Non-current liabilities: | ||||
Long term debt | 0 | 0 | 3.55M | 0 |
Deferred tax | 0 | 0 | 0 | 0 |
Other non-current liabilities | 1.45M | 0 | -3.55M | 0 |
Total non-current liabilities | 11.63M | 65.59K | 3.55M | 0 |
Total liabilities | 91.36M | 8.04M | 8.71M | 10.4K |
| Data source | Data source | Data source |